ERBB2 and breast carcinoma: Breast cancer has been recognized as a heterogeneous disease, and the following four intrinsic molecular subtypes have been identified using PAM50 gene signatures: luminal A, luminal B, HER2-enriched, and basal-like breast cancer [2].